United States v. Richardson

421 F.3d 17, 68 Fed. R. Serv. 123, 2005 U.S. App. LEXIS 18763
CourtCourt of Appeals for the First Circuit
DecidedAugust 30, 2005
Docket04-1617
StatusPublished
Cited by61 cases

This text of 421 F.3d 17 (United States v. Richardson) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Richardson, 421 F.3d 17, 68 Fed. R. Serv. 123, 2005 U.S. App. LEXIS 18763 (1st Cir. 2005).

Opinion

LIPEZ, Circuit Judge.

Defendant-appellant Joanne Richardson appeals her conviction under 18 U.S.C. § 1623 for making false statements during immunized testimony before a grand jury investigating allegations of Medicare/Medicaid fraud. Richardson first contends that the district court erroneously denied her motion to dismiss the indictment because her trial took place after the deadline imposed by the Speedy Trial Act, 18 U.S.C. §§ 1361-74 (“STA”). Next, Richardson asserts that at least one of the nineteen false statements charged against her in a single count of perjury advances a theory of conviction that is contrary to law, requiring that we vacate the jury’s general verdict because it may have rested on an illegal ground. Finally, Richardson challenges the court’s admission of allegedly irrelevant and unduly prejudicial evidence at trial. We reject all of these claims and affirm Richardson’s perjury conviction.

I. BACKGROUND

A. Grand Jury Investigation and Indictment

We set forth the facts “in the light most flattering to the government’s theory of *22 the case, consistent with record support.” United States v. Sebaggala, 256 F.3d 59, 62 (1st Cir.2001). From about 1997 to 2000, Richardson was employed as a Regional Account Manager for TAP Pharmaceuticals Inc. (“TAP”), which manufactures, among other drugs, Lupron, a prescription drug used in the treatment of prostate cancer. Richardson was responsible for maintaining relationships with institutional and managed care customers, including, in 1997, the Lahey Clinic in Burlington, Massachusetts.

In 1999-2000, the government convened a grand jury to investigate allegations that, in violation of federal statutes, TAP and some of its employees had provided “things of value,” including educational grants and free items, (1) as an inducement to certain customers to purchase and prescribe TAP products and/or (2) as a hidden discount to those customers, which allowed TAP to pay reduced rebates to state Medicaid programs based on an artificially inflated invoice or contract price. See 42 U.S.C. § 1320a-7b(b) (prohibiting the offering or paying of and the solicitation or receipt of remuneration “in cash or in kind” in exchange for making certain referrals or for engaging in certain transactions “for which payment may be made in whole or in part under a Federal health care program”); id. § 1396r-8(c)(l)(A), (C) (providing for payment of rebates by drug manufacturers to state Medicaid programs based on difference between “average manufacturer price” and “the lowest price available from the manufacturer during the rebate period”).

Richardson testified before the grand jury pursuant to an order of immunity on October 31, 2000 and December 19, 2000. In response to questioning about her discussions with Lahey Clinic representatives and TAP employees in 1997 regarding renewal of Lahey’s contract with TAP for the clinic’s Lupron purchases, Richardson denied that she had ever offered or discussed offering things of value to Lahey Clinic, in her words, “as a way of reducing [Lupron’s] price outside of a contract form.”

On June 25, 2002, Richardson was indicted on one count of making false statements before a grand jury, 18 U.S.C. § 1623 (Count One), 1 and one count of obstruction of justice, id. § 1503 (Count Two), 2 based on her grand jury testimony of December 19, 2000. On October 31, 2002, the grand jury returned a superseding indictment amending Count One, re-alleging Count Two, and adding one count each of perjury and obstruction of justice (Counts Three and Four) based on a statement Richardson had made in a sworn declaration submitted to the court on September 24, 2002 in opposition to the government’s motion to disqualify her defense counsel.

As amended, Count One alleged that, contrary to nineteen statements she made before the grand jury during her December 19, 2000 grand jury testimony, Richardson had

discussed with, offered[,] and provided to Lahey Clinic things of value outside the written contract as a way of making Lupron cheaper, ... to help make up the difference between the price of Lu- *23 pron and the price of Zoladex, [a competing drug], [and] as an inducement to the Lahey Clinic and some of its employees to ... renew[ ] the contract with TAP and ... to purchase Lupron for patients being treated in the Clinic’s facilities;

and that Richardson had “discussed those arrangements with other[] employees at TAP.” 3 Count One further alleged that “such things of value includ[ed] golf outings, research support, educational grants, free or nominally priced goods, and other items.”

B. Pre-Trial through Post-Trial Proceedings

Richardson moved to dismiss all four counts in the superseding indictment on March 7, 2003, arguing with respect to Count One that the perjury charges against her were insupportable as a matter of law because her statements before the grand jury were literally true, the indictment took those statements out of context, and her statements were made in response to the prosecutor’s fundamentally ambiguous questions during the grand jury colloquy. Judge Stearns heard argument and took the motion under advisement on May 29, 2003. 4

On August 11, 2003, one week before Richardson’s trial was scheduled to begin, Judge Stearns, who had not yet ruled on Richardson’s motion to dismiss the superseding indictment, recused himself. On August 13, 2003, the case was reassigned to Judge Wolf, who immediately recused himself, and then to Judge Lindsay. During the parties’ first appearance before Judge Lindsay on September 22, 2003, Richardson requested a trial date, noting that the time period for trial permitted by the STA either had already expired or was due to expire. Judge Lindsay stated that his trial calendar was booked through much of January, with the exception of the week of October 14, 2003. Richardson acknowledged that an October trial date would leave too little time for Judge Lindsay to decide her motion to dismiss the superseding indictment. Judge Lindsay therefore declined to set a trial date.

On October 16, 2003, Judge Lindsay denied Richardson’s motion to dismiss the superseding indictment. When the parties appeared before Judge Lindsay again on November 17, 2003, he inquired about the speedy trial status of the case. The government stated that the docket showed no ruling by the court on Richardson’s objections to a magistrate judge’s order denying her motion to strike material from the government’s opposition to her motion to dismiss the superseding indictment.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Abdur Islam
Third Circuit, 2026
United States of America v. Crim. P David Berard
2023 DNH 050 (D. New Hampshire, 2023)
United States v. Gottesfeld
18 F.4th 1 (First Circuit, 2021)
United States v. Robert Harra, Jr.
985 F.3d 196 (Third Circuit, 2021)
Medel Corona v. Barr
Second Circuit, 2019
State v. Ferguson
301 Neb. 697 (Nebraska Supreme Court, 2018)
Wbip, LLC v. Kohler Co.
829 F.3d 1317 (Federal Circuit, 2016)
United States v. Laureano-Perez
797 F.3d 45 (First Circuit, 2015)
U.S. v. Apicelli
2015 DNH 109 (D. New Hampshire, 2015)
United States v. Foley
783 F.3d 7 (First Circuit, 2015)
United States v. Souza
749 F.3d 74 (First Circuit, 2014)
United States v. Marston
694 F.3d 131 (First Circuit, 2012)
United States v. James Brooks
681 F.3d 678 (Fifth Circuit, 2012)
United States v. Strohm
671 F.3d 1173 (Tenth Circuit, 2011)
United States v. Bloate
655 F.3d 750 (Eighth Circuit, 2011)
United States v. Mubayyid
658 F.3d 35 (First Circuit, 2011)
Arroyo-Peréz v. Demir Group International
762 F. Supp. 2d 371 (D. Puerto Rico, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
421 F.3d 17, 68 Fed. R. Serv. 123, 2005 U.S. App. LEXIS 18763, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-richardson-ca1-2005.